Home
Conditions
Seminoma

Clinical trial condition

Seminoma

Explore clinical trials studying Seminoma. Study availability and eligibility vary by location and protocol.

16 public trials 7 recruiting studies

Refine in advanced search Browse all conditions

Seminoma trial results

Recruiting

Primary RPLND Versus Systemic Chemotherapy in Good-prognosis Metastatic Testicular Cancer

NCT07498959

Conditions: De-escalation, Endocrine Gland Neoplasms, Endocrine System Diseases, +18 more
Locations: Sahlgrenska University Hospital Gothenburg, Göteborg, Sweden

View Trial Details

Recruiting

THERApy De-escalation for TESTicular Cancer

NCT06309745

Conditions: Germinoma, Neoplasms, Neoplasms by Histologic Type, +2 more
Locations: Barts and London Hospital NHS Trust London, United Kingdom

View Trial Details

Recruiting

PRIMETEST II - Clinical Stage II A/B Seminoma Treated With RA-RPLND

NCT06144736

Conditions: Germinoma, Neoplasms, Neoplasms by Histologic Type, +2 more
Locations: University Hospital of Duesseldorf Düsseldorf, Germany

View Trial Details

Recruiting

Robot-assisted ICG-guided Sentinel Node Biopsy in Testicular Cancer

NCT06133543

Conditions: Germ Cell Tumor, Germinoma, Neoplasms, +5 more
Locations: University Hospital of Duesseldorf Düsseldorf, Germany

View Trial Details

Recruiting

Radiotherapy vs Observation for Post Chemotherapy Residual Mass in Advanced Seminoma

NCT05142982

Conditions: Germinoma, Neoplasms, Neoplasms by Histologic Type, +2 more
Locations: Tata Memorial Centre Mumbai, Maharashtra, India

Dr Vedang Murthy Navi Mumbai, Maharashtra, India

View Trial Details

Recruiting

De-escalation Study for Stage IIa/IIb < 3 cm Seminoma

NCT05529251

Conditions: Germinoma, Neoplasms, Neoplasms by Histologic Type, +3 more
Locations: CHU Besançon Besançon, France

CHU Bordeaux Bordeaux, France

Centre François Baclesse Caen, France

Centre Jean Perrin Clermont-Ferrand, France

View all 15 locations

View Trial Details

Recruiting

MicroRNA as Markers in Testicular Cancer

NCT04914026

Conditions: Endocrine Gland Neoplasms, Endocrine System Diseases, Genital Diseases, +21 more
Locations: Haukeland University Hospital Bergen, Norway

Haugesund Hospital Haugesund, Norway

Oslo University Hospital Oslo, Norway

University Hospital of North Norway Tromsø, Norway

View Trial Details

Not Yet Recruiting

PRISTINE Trial: PRoton Beam Therapy In Seminoma - Toxicity INvestigation and Evaluation of Outcome

NCT07601672

Conditions: Germinoma, Neoplasms, Neoplasms by Histologic Type, +2 more
Locations: Not specified

View Trial Details

Completed

Cardiac Function and Cardiovascular Risk Profile in Testicular Cancer Patients

NCT00705094

Conditions: Endocrine Gland Neoplasms, Endocrine System Diseases, Genital Diseases, +16 more
Locations: Cross Cancer Institute Edmonton, Alberta, Canada

View Trial Details

Active, Not Recruiting

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

NCT02834013

Conditions: Acinar Cell Carcinoma, Adenocarcinoma, Adenocarcinoma of Lung, +207 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States

Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States

Anchorage Radiation Therapy Center Anchorage, Alaska, United States

View all 1007 locations

View Trial Details

Seminoma

Seminoma trial results

Related conditions